A 784168TRPV1 antagonist,potent and selective CAS# 824982-41-4 |
- KX2-391 dihydrochloride
Catalog No.:BCC1686
CAS No.:1038395-65-1
- Dasatinib (BMS-354825)
Catalog No.:BCC1281
CAS No.:302962-49-8
- Saracatinib (AZD0530)
Catalog No.:BCC1166
CAS No.:379231-04-6
- Bosutinib (SKI-606)
Catalog No.:BCC1167
CAS No.:380843-75-4
- Dasatinib hydrochloride
Catalog No.:BCC1517
CAS No.:854001-07-3
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 824982-41-4 | SDF | Download SDF |
PubChem ID | 11420211 | Appearance | Powder |
Formula | C19H15F6N3O3S | M.Wt | 479.4 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 100 mM in DMSO and to 50 mM in ethanol | ||
Chemical Name | 1-[3-(trifluoromethyl)pyridin-2-yl]-N-[4-(trifluoromethylsulfonyl)phenyl]-3,6-dihydro-2H-pyridine-4-carboxamide | ||
SMILES | C1CN(CC=C1C(=O)NC2=CC=C(C=C2)S(=O)(=O)C(F)(F)F)C3=C(C=CC=N3)C(F)(F)F | ||
Standard InChIKey | SDUAWRFBHRAFBM-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C19H15F6N3O3S/c20-18(21,22)15-2-1-9-26-16(15)28-10-7-12(8-11-28)17(29)27-13-3-5-14(6-4-13)32(30,31)19(23,24)25/h1-7,9H,8,10-11H2,(H,27,29) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Potent TRPV1 antagonist (IC50 = 25 nM for inhibition of TRPV1 activation by 50 nM capsaicin). Displays no activity against a range of receptors, including TRPA1, GABA, opioid, and purinergic receptors. |
A 784168 Dilution Calculator
A 784168 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.0859 mL | 10.4297 mL | 20.8594 mL | 41.7188 mL | 52.1485 mL |
5 mM | 0.4172 mL | 2.0859 mL | 4.1719 mL | 8.3438 mL | 10.4297 mL |
10 mM | 0.2086 mL | 1.043 mL | 2.0859 mL | 4.1719 mL | 5.2149 mL |
50 mM | 0.0417 mL | 0.2086 mL | 0.4172 mL | 0.8344 mL | 1.043 mL |
100 mM | 0.0209 mL | 0.1043 mL | 0.2086 mL | 0.4172 mL | 0.5215 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- LP 44
Catalog No.:BCC7399
CAS No.:824958-12-5
- Baicalin methyl ester
Catalog No.:BCN3252
CAS No.:82475-03-4
- Oroxylin A 7-O-beta-D-glucuronide methyl ester
Catalog No.:BCN1339
CAS No.:82475-01-2
- Neokadsuranin
Catalog No.:BCN7816
CAS No.:115181-68-5
- R(+)-Gomisin M1
Catalog No.:BCN4362
CAS No.:82467-50-3
- 3-Oxotirucalla-7,24-dien-21-oic acid
Catalog No.:BCN4568
CAS No.:82464-35-5
- Hispanone
Catalog No.:BCN7404
CAS No.:82462-67-7
- Arteannuin A
Catalog No.:BCN4361
CAS No.:82442-48-6
- Pulchinenoside E3
Catalog No.:BCN8187
CAS No.:824401-07-2
- Agomelatine L(+)-Tartaric acid
Catalog No.:BCC4211
CAS No.:824393-18-2
- Maglifloenone
Catalog No.:BCN4360
CAS No.:82427-77-8
- Gomisin M2
Catalog No.:BCN4359
CAS No.:82425-45-4
- Pseudolaric Acid B
Catalog No.:BCN6284
CAS No.:82508-31-4
- Pseudolaric acid A
Catalog No.:BCN3717
CAS No.:82508-32-5
- Methyl pseudolarate A
Catalog No.:BCN4363
CAS No.:82508-33-6
- Methyl pseudolarate B
Catalog No.:BCN4364
CAS No.:82508-34-7
- Demethoxydeacetoxypseudolaric acid B
Catalog No.:BCN4365
CAS No.:82508-36-9
- Deacetylpseudolaric acid A
Catalog No.:BCN4366
CAS No.:82508-37-0
- 10-Hydroxy-16-epiaffinine
Catalog No.:BCN4001
CAS No.:82513-70-0
- 5-Methyl-7-methoxyisoflavone
Catalog No.:BCN8465
CAS No.:82517-12-2
- Myoscorpine
Catalog No.:BCN1973
CAS No.:82535-76-0
- Fmoc-Phe(4-I)-OH
Catalog No.:BCC3261
CAS No.:82565-68-2
- Ozagrel
Catalog No.:BCC2298
CAS No.:82571-53-7
- Moexipril HCl
Catalog No.:BCC5015
CAS No.:82586-52-5
[3H]A-778317 [1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a novel, stereoselective, high-affinity antagonist is a useful radioligand for the human transient receptor potential vanilloid-1 (TRPV1) receptor.[Pubmed:17660385]
J Pharmacol Exp Ther. 2007 Oct;323(1):285-93.
1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea (A-778317) is a novel, stereoselective, competitive antagonist that potently blocks transient receptor potential vanilloid-1 (TRPV1) receptor-mediated changes in intracellular calcium concentrations (pIC50 = 8.31 +/- 0.13). The (S)-stereoisomer, 1-((S)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea (A-778316), is 6.8-fold less potent (pIC50 = 7.47 +/- 0.07). A-778317 also potently blocks capsaicin and acid activation of native rat TRPV1 receptors in dorsal root ganglion neurons. A-778317 was tritiated ([3H]A-778317; 29.3 Ci/mmol) and used to study recombinant human TRPV1 (hTRPV1) receptors expressed in Chinese ovary cells (CHO) cells. [3H]A-778317 labeled a single class of binding sites in hTRPV1-expressing CHO cell membranes with high affinity (KD = 3.4 nM; Bmax = 4.0 pmol/mg protein). Specific binding of 2 nM [3H]A-778317 to hTRPV1-expressing CHO cell membranes was reversible. The rank-order potency of TRPV1 receptor antagonists to inhibit binding of 2 nM [3H]A-778317 correlated well with their functional potencies in blocking TRPV1 receptor activation. The present data demonstrate that A-778317 blocks polymodal activation of the TRPV1 receptor by binding to a single high-affinity binding site and that [3H]A-778317 possesses favorable binding properties to facilitate further studies of hTRPV1 receptor pharmacology.
TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists.[Pubmed:16971522]
J Neurosci. 2006 Sep 13;26(37):9385-93.
Vanilloid receptor type 1 (TRPV1) is a ligand-gated nonselective cation channel that is considered to be an important integrator of various pain stimuli such as endogenous lipids, capsaicin, heat, and low pH. In addition to expression in primary afferents, TRPV1 is also expressed in the CNS. To test the hypothesis that the CNS plays a differential role in the effect of TRPV1 antagonists in various types of pain, the analgesic effects of two TRPV1 antagonists with similar in vitro potency but different CNS penetration were compared in vivo. Oral administration of either A-784168 (1-[3-(trifluoromethyl)pyridin-2-yl]-N-[4-(trifluoromethylsulfonyl)phenyl]-1,2,3, 6-tetrahydropyridine-4-carboxamide) (good CNS penetration) or A-795614 (N-1H-indazol-4-yl-N'-[(1R)-5-piperidin-1-yl-2,3-dihydro-1H-inden-1-yl]urea) (poor CNS penetration) blocked capsaicin-induced acute pain with the same potency. In complete Freund's adjuvant (CFA)-induced chronic inflammatory pain, oral administration of either compound blocked thermal hyperalgesia with similar potency. Furthermore, intraplantar or intrathecal administration of A-784168 blocked CFA-induced thermal hyperalgesia, suggesting that both peripheral and CNS TRPV1 receptors may play a role in inflammatory thermal hyperalgesia. The effects of the two TRPV1 antagonists were further assessed in models presumably mediated by central sensitization, including CFA- and capsaicin-induced mechanical allodynia and osteoarthritic pain. In these models, the potency of the two compounds was similar after intrathecal administration. However, when administered orally, A-784168, with good CNS penetration, was much more potent than A-795614. Together, these results demonstrate that TRPV1 receptors in the CNS play an important role in pain mediated by central sensitization. In addition, these results demonstrate that significant CNS penetration is necessary for a TRPV1 antagonist to produce broad-spectrum analgesia.